• About us
• Contact

Advertisement

Product › Details

cancer drug

	Next higher product group	pharmaceutical
	Status	1998-01-01 sales existent

Record changed: 2025-01-20

Advertisement

More documents for cancer drug

• [1] Coulter Partners. (1/23/25). "Press Release: Coulter Partners Secures CEO Placement for NeoPhore"....
• [2] ITM Isotope Technologies Munich SE. (1/16/25). "Press Release: Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO". Chalk River, ON....
• [3] ITM Isotope Technologies Munich SE. (1/13/25). "Press Release: ITM and Ariceum Therapeutics Enter into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225". Garching, Munich & Berlin....
• [4] Daiichi Sankyo Co., Ltd.. (1/13/25). "Press Release: Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH". Tokyo & Basking Ridge, NJ....
• [5] GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London....
• [6] Innovent Biologics, Inc.. (1/2/25). "Press Release: Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate". San Francisco, CA & Suzhou....
• [7] BeiGene, Ltd.. (12/23/24). "Press Release: BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference". San Mateo, CA....
• [8] Y-mAbs Therapeutics, Inc.. (12/23/24). "Press Release: Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare Conference". New York, NY....
• [9] Innovent Biologics, Inc.. (12/20/24). "Press Release: Innovent Receives Approval of Dovbleron (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China’s National Medical Products Administration". San Francisco, CA & Suzhou....
• [10] Ottimo Pharma Ltd.. (12/19/24). "Press Release: Ottimo Pharma Raises over $140 Million in Series A Financing". London & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.